Bionik Laboratories (BNKL) Short Interest Ratio & Short Volume

Short interest is the volume of Bionik Laboratories shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 100 shares of BNKL short. Learn More on Bionik Laboratories' current short interest.

Bionik Laboratories saw a increase in short interest in June. As of June 15th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "medical equipment" compare to Bionik Laboratories: Endonovo Therapeutics, Inc. (0.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Corporation ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks.

Short selling BNKL is an investing strategy that aims to generate trading profit from Bionik Laboratories as its price is falling. BNKL shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bionik Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BNKL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNKL, twice per month. The most recent reporting period available is June, 15 2023.